2018 Update: Anticoagulation, Thrombosis, Thrombophilia
| Date Posted: 11/30/2017
You are invited to attend a program 2018
2018 Update: Anticoagulation, Thrombosis, Thrombophilia
January 24, 2018
Dinner at 5:45 p.m.
Program to follow at 6:15 p.m.
Conference Center • FirstHealth Moore Regional Hospital Pinehurst, NC
Target Audience: All Physicians and Interested Health Care Professionals
Speaker: Stephen Moll, M.D.
Dr. Moll completed his medical degree at Freiburg University in Freiburg, Germany. He completed his internship in Pathology at the University of Aachen in Aachen, Germany. He also completed an internship and residency in Internal Medicine at Duke University Medical Center in Durham, NC. Dr. Moll completed his fellowships in Coagulation at the University of North Carolina at Chapel Hill and in Hematology-Oncology at Duke University Medical Center. Dr. Moll is professionally associated with the University of North Carolina at Chapel Hill School of Medicine.
Objectives: At the completion of this activity, the participant should be able to:
• Decide which patient with DVT is suitable for pharmaco-mechanical thrombectomy.
• Weigh the pros and cons of the different anticoagulants before initiating anticoagulation in the patient with DVT or PE.
• Use the appropriate anticoagulant in special patient populations with DVT or PE, such as the patient who is obese, underwent bariatric surgery, is elderly, has cancer or renal failure.
• Direct a patient who cannot afford the copay for one of the new oral anticoagulants to the appropriate resources.
• Advise a patient interested in taking testosterone on the thrombotic risk.
• Make decisions on which patient to test for thrombophilia, which tests to obtain, and correctly interpret the test results.
Professional Practice Gap to be filled: Lack of most recent knowledge for anticoagulant therapy
